NCT06696287

Brief Summary

The aim of our study is to investigate the validity and reliability of the 6-minute pegboard and ring test in patients with fibromyalgia syndrome.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
28

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 3, 2024

Completed
17 days until next milestone

First Posted

Study publicly available on registry

November 20, 2024

Completed
7 days until next milestone

Study Start

First participant enrolled

November 27, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

December 2, 2024

Status Verified

October 1, 2024

Enrollment Period

6 months

First QC Date

November 3, 2024

Last Update Submit

November 27, 2024

Conditions

Fibromyalgia

Outcome Measures

Primary Outcomes (3)

  • Arm exercise capacity

    It will be assessed by 6 minute pegboard and ring test.

    10 minutes

  • Functional exercise capacity

    It will be evaluated using arm ergometer test.

    20 minutes

  • Hand grip strength

    Will be measured using a hang grip dynamometer.

    5 minutes

Secondary Outcomes (2)

  • Activities of daily living

    10 minutes

  • Functional status/limitation

    5 minutes

Study Arms (1)

Patients with fibromyalgia

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals aged 18-65 years who are clinically stable and diagnosed with fibromyalgia syndrome and who are being followed up at the Rheumatology Polyclinic of the Department of Physical Medicine and Rehabilitation at Kirsehir Ahi Evran University will be included in the study.

You may qualify if:

  • Being diagnosed with fibromyalgia syndrome
  • Being aged 18-65
  • Stable use of medication for at least 3 months or longer
  • Volunteering to participate in the study

You may not qualify if:

  • Having a musculoskeletal problem that would prevent being tested
  • Having cardiopulmonary and neurological disease
  • Malignancy
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kirsehir Ahi Evran University

Kırşehir, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Fibromyalgia

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Study Officials

  • Basak Kavalci Kol

    Kirsehir Ahi Evran University

    STUDY CHAIR

  • Figen Tuncay

    Kirsehir Ahi Evran University

    STUDY CHAIR

Central Study Contacts

Merve Firat

CONTACT

+90 850 441 02 44mervefirat@ahievran.edu.tr

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst. Prof.

Study Record Dates

First Submitted

November 3, 2024

First Posted

November 20, 2024

Study Start

November 27, 2024

Primary Completion

June 1, 2025

Study Completion

November 1, 2025

Last Updated

December 2, 2024

Record last verified: 2024-10

Locations

TU(1)